Fri, Feb 02, 2024
At around 10:58 a.m., shares of Abbott India traded 8.5 per cent, or Rs 2,202.85, higher at Rs 28,119.95 apiece. The market capitalisation of the company at around the same time stood at Rs 59,752.93 crore.
More >
Fri, Sep 15, 2023
Abbott India new: Goa state has warned the local unit of Abbott Laboratories (ABT.N) it plans to suspend the manufacturing licence of its antacid medicine after inspectors flagged contamination risks and sanitization issues at its factory, government documents show.
Thu, Apr 27, 2023
The batch has been invoiced only in Madhya Pradesh and Telangana, it added. Patients who have recently purchased Thyronorm with batch no AEJ0713 are requested to return the bottle to the chemist they purchased it from or notify the company, Abbott India said.
Tue, May 17, 2022
Q4 Results 2022: Real estate player DLF Limited and drug company Abbott India announced their March quarter results on Tuesday. Here are keyhighlights of the results
Wed, Dec 16, 2020
CLSA highlights that it was a muted month for pharma companies as November sales disappoint for the Domestic Market. CLSA says it was a strong month for IPCA Labs; gains from integration of acquired brands for Dr Reddy. Falling active cases meant sales of Covid treatment drugs moderated for Glenmark / Cipla (+16%/-24% MoM). Glenmark saw the highest growth in its coverage in November, but excluding these products, its portfolio fell 1% YoY. Cipla’s core growth was a smaller 5.9% YoY.
Mon, Aug 27, 2018
“Abbott plans to launch around 100 products over the next five years. Our focus remains on growing existing therapy areas such as gastroenterology, metabolics, vaccines, central nervous system and women’s health,” the company’s managing director Ambati Venu said.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.